In the current study, we investigated whether Staphylococcus aureus grown from affected skin of atopic dermatitis (AD) patients secreted identifiable toxins that could act as allergens to induce IgE-mediated basophil histamine release. The secreted toxins of S. aureus grown from AD patients were identified by ELISA using antibodies specific for staphylococcal enterotoxin (SE) exfoliative toxin (ET), or toxic shock syndrome toxin (TSST-1). S. aureus isolates from 24 of 42 AD patients secreted identifiable toxins with SEA, SEB, and TSST accounting for 92% of the isolates. 32 of 56 AD sera (57%) tested contained significant levels of IgE primarily to SEA, SEB, and/or TSST. In contrast, although SEA, SEB, or TSST secreting S. aureus could be recovered from the skin of psoriasis patients, their sera did not contain IgE antitoxins. Freshly isolated basophils from 10 AD patients released 5-59% of total histamine in response to SEA, SEB, or TSST-1 but only with toxins to which patients had specific IgE. Basophils from eight other AD patients and six normal controls who had no IgE antitoxin failed to demonstrate toxin-induced basophil histamine release. Stripped basophils sensitized with three AD sera containing IgE to toxin released 15-41% of total basophil histamine only when exposed to the relevant toxin, but not to other toxins. Sensitization of basophils with AD sera lacking IgE antitoxin did not result in release of histamine to any of the toxins tested. These data indicate that a subset of patients with AD mount an IgE response to SEs that can be grown from their skin. These toxins may exacerbate AD by activating mast cells, basophils, and/or other Fc epsilon-receptor bearing cells armed with the relevant IgE antitoxin.
D Y Leung, R Harbeck, P Bina, R F Reiser, E Yang, D A Norris, J M Hanifin, H A Sampson
Title and authors | Publication | Year |
---|---|---|
Emerging therapeutic options for atopic dermatitis: Beyond TIMs
ER Conner, LA Beck |
Current Allergy and Asthma Reports | 2006 |
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report
CA Akdis, M Akdis, T Bieber, C Bindslev-Jensen, M Boguniewicz, P Eigenmann, Q Hamid, A Kapp, DY Leung, J Lipozencic, TA Luger, A Muraro, N Novak, TA Platts-Mills, L Rosenwasser, A Scheynius, FE Simons, J Spergel, K Turjanmaa, U Wahn, S Weidinger, T Werfel, T Zuberbier |
Allergy | 2006 |
Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B
PW Hellings, G Hens, I Meyts, D Bullens, J Vanoirbeek, P Gevaert, M Jorissen, JL Ceuppens, C Bachert |
Clinical & Experimental Allergy | 2006 |
The role of microorganisms in atopic dermatitis
BS Baker |
Clinical & Experimental Immunology | 2006 |
Anti-microbial photodynamic therapy: useful in the future?
T Maisch |
Lasers in Medical Science | 2006 |
Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis
Y Hashimoto, I Arai, N Takano, M Tanaka, S Nakaike |
British Journal of Dermatology | 2006 |
The Importance of Bacterial Superantigens Produced by <i>Staphylococcus aureus</i> in the Treatment of Atopic Dermatitis Using Povidone-Iodine
K Sugimoto, N Ishikawa, T Terano, Y Kitukawa, H Kubosawa, S Ito, T Hattori |
Dermatology | 2006 |
Aldehyde modification of peptide immunogen enhances protein-reactive antibody response to toxic shock syndrome toxin-1
A Bavoso, A Ostuni, JD Vendel, F Pollaro, F Armentano, T Knight, S Makker, A Tramontano |
Journal of Peptide Science | 2006 |
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial
JQ Gong, L Lin, T Lin, F Hao, FQ Zeng, ZG Bi, D Yi, B Zhao |
British Journal of Dermatology | 2006 |
Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis
SH Silva, AC Guedes, B Gontijo, AM Ramos, LS Carmo, LM Farias, JR Nicoli |
Journal of the European Academy of Dermatology and Venereology | 2006 |
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial
LC Parish, JL Jorizzo, JJ Breton, JW Hirman, NE Scangarella, RM Shawar, SM White |
Journal of the American Academy of Dermatology | 2006 |
The Comprehensive Sourcebook of Bacterial Protein Toxins
JD Dubreuil |
The Comprehensive Sourcebook of Bacterial Protein Toxins | 2006 |
Principles of Molecular Medicine
MS Runge, C Patterson |
2006 | |
Handbook of Atopic Eczema
J Ring, B Przybilla, T Ruzicka |
2006 | |
Effects of Photocatalytic Agent on DS-Nh Mice, Developing Atopic Dermatitis-Like Eruption with an Increase of Staphylococcus aureus
T Kambara, M Aihara, S Matsukura, I Sato, Y Kubota, T Hirasawa, Z Ikezawa |
International Archives of Allergy and Immunology | 2006 |
The Role of Immune Response to Staphylococcus aureus Superantigens and Disease Severity in Relation to the Sensitivity to Tacrolimus in Atopic Dermatitis
H Fukushima, T Hirano, N Shibayama, K Miwa, T Ito, M Saito, H Sumida, S Oyake, R Tsuboi, K Oka |
International Archives of Allergy and Immunology | 2006 |
Increased Expression of RANTES, CCR3 and CCR5 in the Lesional Skin of Patients with Atopic Eczema
Y Kato, R Pawankar, Y Kimura, S Kawana |
International Archives of Allergy and Immunology | 2006 |
Allergic Fungal Sinusitis
MS Schubert |
Clinical Reviews in Allergy & Immunology | 2006 |